Japan at a glance
- Population
- 123.4 million 2025
- Life expectancy at birth
- 84.0 years, 2024
- People aged 65 and over
- 30.0 % of people, 2025
- Health spending per person
- 3,638 US$ per person, 2023
- Doctors
- 2.65 per 1,000 people, 2022
Updated
Reviewed by Chandani Patel
Japan Omega-3 Supplements Market Industry Trends and Forecast to 2034: Segmented by (Source, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$429.6 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $420.0 Mn | — | — |
| 2025 (base) | $452.4 Mn | +$32.3 Mn | — |
| 2026 (forecast) | $487.2 Mn | +$34.8 Mn | +7.7% |
| 2027 (forecast) | $524.7 Mn | +$37.5 Mn | +16% |
| 2028 (forecast) | $565.1 Mn | +$40.4 Mn | +24.9% |
| 2029 (forecast) | $608.6 Mn | +$43.5 Mn | +34.5% |
| 2030 (forecast) | $655.5 Mn | +$46.9 Mn | +44.9% |
| 2031 (forecast) | $706.0 Mn | +$50.5 Mn | +56.1% |
| 2032 (forecast) | $760.3 Mn | +$54.4 Mn | +68.1% |
| 2033 (forecast) | $818.9 Mn | +$58.5 Mn | +81% |
| 2034 (forecast) | $881.9 Mn | +$63.1 Mn | +95% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $452.4 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $881.9 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 7.7% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Source, form and distribution channel (see all) |
| Key players | Nordic Naturals, DSM-Firmenich, Aker BioMarine, Pharmavite LLC, Carlson Labs (see all) |
| Regulator in Japan | PMDA and Consumer Affairs AgencySource: Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.Source: Consumer Affairs Agency. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Omega-3 supplements provide EPA and DHA fatty acids from fish, krill or algae, for heart, brain and eye health.
Key segments of the omega-3 Supplements market include source (Fish Oil, Krill Oil and Algal Oil) and form (Softgels, Liquids and Gummies).
Growing interest in prevention, social media trends, ageing consumers, sports nutrition going mainstream and easy online shopping are driving the omega-3 Supplements market.
Personalised nutrition, clinically tested ingredients and new formats such as gummies and drinks give the omega-3 Supplements market strong room to grow.
Mixed scientific evidence, quality and safety concerns, strict health-claim rules and price competition hold back the omega-3 Supplements market.
The omega-3 Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Drugs are reviewed by the Pharmaceuticals and Medical Devices Agency (PMDA) and approved by the Ministry of Health, Labour and Welfare (MHLW).[1] Foods with health claims, such as FOSHU and Foods with Function Claims, come under the Consumer Affairs Agency.[2]
[1] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.
[2] Consumer Affairs Agency. Checked 14 Nov 2026.
Food and supplement rules, labelling and health-claim regulations govern omega-3 Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in Japan.
What doctors and scientists are doing in Omega-3 Supplements right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.
From our blog
Japan · 2 shared keywords
Japan · 1 shared keyword
Japan · 1 shared keyword
Japan · 1 shared keyword
Japan · 1 shared keyword
Japan · 1 shared keyword
Digital Health · Japan
Pharmaceuticals · Japan
Medical Devices · Japan
Medical Devices · Japan
Pharmaceuticals · Japan
Pharmaceuticals · Japan